Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Gains from Investment Securities: 2011-2024

Historic Gains from Investment Securities for Verastem (VSTM) over the last 13 years, with Dec 2024 value amounting to $19.1 million.

  • Verastem's Gains from Investment Securities rose 515.26% to $55.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.6 million, marking a year-over-year increase of 626.35%. This contributed to the annual value of $19.1 million for FY2024, which is N/A change from last year.
  • Per Verastem's latest filing, its Gains from Investment Securities stood at $19.1 million for FY2024, which was up 1,539.32% from $1.2 million recorded in FY2022.
  • In the past 5 years, Verastem's Gains from Investment Securities ranged from a high of $19.1 million in FY2024 and a low of $285,000 during FY2020.
  • Its 2-year average for Gains from Investment Securities is $10.2 million, with a median of $10.2 million in 2022.
  • Data for Verastem's Gains from Investment Securities shows a peak YoY surged of 319.12% (in 2020) over the last 5 years.
  • Verastem's Gains from Investment Securities (Yearly) stood at $285,000 in 2020, then surged by 224.56% to $925,000 in 2021, then increased by 26.28% to $1.2 million in 2022, then reached $19.1 million in 2024.